Yang CH, Lee JN, Hsu SC, et al. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women—a 3-year study. Maturitas 2002;43:35–39.
34.
Reed SD, Cushing-Haugen KL, Daling JR, et al. Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas. Menopause 2004;11:214–222.
35.
Parazzini F, Negri E, La Vecchia C, et al. Reproductive factors and risk of uterine fibroids. Epidemiology 1996;7:440–442.
36.
Lumbiganon P, Rugpao S, Phandhu-fung S, et al. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol 1996;103:909–914.
37.
Baird DD, Dunson DB. Why is parity protective for uterine fibroids? Epidemiology 2003;14:247–250.
38.
Cesen-Cummings K, Houston KD, Copland JA, et al. Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling. J Soc Gynecol Investig 2003;10:11–20.
39.
Burbank F. Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology? J Am Assoc Gynecol Laparosc 2004;11:138–152.
40.
Barbieri RL, McShane PM, Ryan KJ. Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertil Steril 1986;46:232–236.
41.
Michnovicz JJ, Hershcopf RJ, Naganuma H, et al. Increased 2hydroxylation of estradiol as a possible mechanism for the antiestrogenic effect of cigarette smoking. N Engl J Med 1986;315:1305– 1309.
42.
Daniel M, Martin AD, Drinkwater DT. Cigarette smoking, steroid hormones, and bone mineral density in young women. Calcif Tissue Int 1992;50:300–305.
43.
Cramer SF, Mann L, Calianese E, et al. Association of seedling myomas with myometrial hyperplasia. Hum Pathol 2009;40:218–225.
44.
Rowe MK, Kanouse DE, Mittman BS, et al. Quality of life among women undergoing hysterectomies. Obstet Gynecol 1999;93:915– 921.
45.
Davis BJ, Haneke KE, Miner K, et al. The fibroid growth study: determinants of therapeutic intervention. J Womens Health (Larchmt) 2009;18:725–732.
46.
Munro MG, Lukes AS. Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process. Fertil Steril 2005;84:1335–1337.
47.
Marino JL, Eskenazi B, Warner M, et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod 2004;19:2350–2355.
48.